DV
Dividend Vision

RXRX — Recursion Pharmaceuticals Inc.

Recursion Pharmaceuticals Inc. (RXRX)

Total return is -89.9% over the past 5.3 years, 189.6 points behind SPY at 99.7%. Its deepest 1-year drawdown was 58.2%.

RXRX is an equity fund that tracks Recursion Pharmaceuticals Inc., a single-stock holding focused on the pharmaceutical and biotechnology sector. As a concentrated single-stock position, it does not distribute dividends and carries no stated expense ratio or asset under management data. This fund structure appeals primarily to investors seeking direct exposure to Recursion Pharmaceuticals' growth potential rather than income-focused dividend investors.

RXRX key facts

Asset type
Stock
Asset class
Equity
Inception date
04/16/2021
Distribution frequency
None
Last close
$3.16
Market cap
$1,694,616,576
Average volume
10508600.0
Beta
1.054
Payout ratio
0.0
Forward P/E
0.0
EPS
$-0.95